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European Journal of Cardio-thoracic Surgery 40 (2011) 858—868SummaryThoracic endovascular aortic repair (TEVAR) has emerged as a promising therapeutic alternative to conventional open aortic replacement but it
requires suitable proximal and distal landing zones for stent-graft anchoring. Many aortic pathologies affect in the immediate proximity of the left
subclavian artery (LSA) limiting the proximal landing zone site without proximal vessel coverage. In patients in whom the distance between the LSA
and aortic lesion is too short, extension of the landing zone can be obtained by covering the LSA’s origin with the endovascular stent graft (ESG). This
manoeuvre has the potential for immediate and delayed neurological and vascular symptoms. Some authors, therefore, propose prophylactic
revascularisation of the LSA by transposition or bypass, while others suggest prophylactic revascularisation only under certain conditions, and still
others see no requirement for prophylactic revascularisation in anticipation of LSA ostium coverage. In this review about LSA revascularisation in
TEVAR patientswith coverage of the LSA, we searched the electronic databases MEDLINE and EMBASE historically until the end date ofMay 2010with
the search terms left subclavian artery, covering, endovascular, revascularisation and thoracic aorta.We have gathered themost complete scientific
evidence available used to support the various concepts to dealwith this issue. After a reviewof the current available literature, 23 relevant articles
were found, where we have identified and analysed three basic treatment concepts for LSA revascularisation in TEVAR patients (prophylactic,
conditional prophylactic and no prophylactic LSA revascularisation). The available evidence supports prophylactic revascularisation of the LSA
beforeESGLSAcoveragewhenpreoperative imaging reveals abnormal supra-aortic vascularanatomyorpathology.We further concludethatelective
patients undergoing planned coverage of the LSA during TEVAR should receive prophylactic LSA transposition or LSA-to-left-common-carotid-artery
(LCCA) bypass surgery to prevent severe neurological complications, such as paraplegia or brain stem infarction.
# 2011 European Association for Cardio-Thoracic Surgery. Published by Elsevier B.V. All rights reserved.
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revascularisation of the left subclavian artery1. Introduction
Most thoracic aortic pathologies are serious conditions
demanding referral to highly specialised cardiovascular* Corresponding author. Tel.: +49 6131 172106; fax: +49 6131 175513.
E-mail address: weigang@uni-mainz.de (E. Weigang).
1 Both authors contributed equally to the article.
2 Members of the Vascular Disease Domain of the European Association for
Cardio-thoracic Surgery.
1010-7940/$ — see front matter # 2011 European Association for Cardio-Thoracic S
doi:10.1016/j.ejcts.2011.01.046centres with a sustained expertise with complex cases.
The estimated yearly incidence of thoracic aortic aneurysms
(TAAs) is six cases per 100,000 [1,2], and of acute aortic
dissection 10—20 cases per million [1]. Conventional treat-
ment consists of surgical replacement of the diseased aortic
segment with a vascular graft: this requires thoracotomy,
aortic cross-clamping and, occasionally, cardiopulmonary
bypass with hypothermic circulatory arrest and antegrade
selective cerebral perfusion. Some operative procedures are
extensive, often technically complex and may be associated
with substantial morbidity, including bleeding, paraplegia,urgery. Published by Elsevier B.V. All rights reserved.
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ventilatory support [3—5], as well as substantial mortality
[6—8]. Thoracic endovascular aortic repair (TEVAR) for aortic
disease has, since its introduction by Dake [9], emerged as a
promising therapeutic alternative to conventional operative
treatment. It is a less invasive method associated with
considerably lower mortality and morbidity [10—15]. This
treatment method is based on the principle of segmental
exclusion with an endovascular stent graft (ESG) [11,14,16].
However, TEVAR requires suitable proximal and distal landing
zones for stable ESG fixation. It has been suggested [17,18]
that 2 cm of normal aortic wall are required for adequate and
stable sealing. Unfortunately, many diseases and injuries of
the thoracic aorta occur in the immediate proximity of the
origin of the supra-aortic branches, such as the left
subclavian artery (LSA). In patients in whom the distance
between the LSA and the aortic lesion is too short or in those
in which the LSA ostium is located within the aortic
pathology, extension of the landing zone can be obtained
by covering the LSA’s ostium with the ESG or positioning the
proximal margin of the endoprosthesis directly on the ostium
of the LSA [19,20].
However, there are reports of delayed onset of verteb-
robasilary insufficiency and arm ischaemia [21,22], following
LSA covering with ESGs. Insufficient blood supply to the
posterior cerebral circulation may evolve in the presence of
hypoplasia of the right vertebral artery (VA) and/or posterior
communicating arteries (PCOMAs) exits [23]. Surgical
transposition of the LSA to the left common carotid artery
(LCCA) or LCCA-to-LSA bypass prior to TEVAR with LSA
coveringmay preserve blood flow to the brain stem and spinal
cord [1,12]. Alternatively, a branched ESG approach can be
implemented [24,25].
In the current review, we outline various strategies that
have been advocated to manage and treat patients requiring
covering of the LSA with ESG.2. Material and methods
A review of the relevant available literature was
performed by searching the complete electronic MEDLINE
and EMBASE databases historically until the end date of May
2010. The terms left subclavian artery, covering, endovas-
cular, revascularisation and thoracic aorta were used as
search terms. All relevant publications were selected and
analysed. Only cases of isolated complete covering of the LSA
ostium were included. All complications were documented,
independent of interpretation.3. Results of the review
3.1. Prophylactic LSA revascularisation
Some authors recommend prophylactic LSA transposition
or LSA bypass prior to intentional LSA covering. In a series by
Grabenwo¨ger et al. in 2000 [26], 21 patients received TEVAR,
of whom 19 presented a descending aortic aneurysm and two
an aortic dissection. In that series, nine patients (42.9%)
underwent prophylactic LSA transposition before coveringthe LSA because of a short proximal neck. There were no
neurological complications, although the distal thoracic
aorta was covered in seven patients without postoperative
paraplegia. The authors suggested two possible explanations
for their observations. First, in the case of atherosclerotic
aneurysms, collaterals supply the spinal cord, and many
intercostal branches may be already occluded by thrombotic
material. Second, the sudden deployment of the ESG
followed by the occlusion of the intercostal branches does
not produce a steal phenomenon in spinal cord perfusion
[27]. In a subsequent study [28], 19 patients with acute
thoracic aortic syndrome were treated with TEVAR, and only
one suffered left-arm ischaemia requiring secondary revas-
cularisation by LSA transposition. Another patient without
LSA revascularisation developed paraparesis, which was
managed successfully by cerebrospinal fluid drainage for
72 h without residual neurological deficit. These authors
seem to have changed their strategy and decided not to
perform prophylactic LSA transposition before covering the
LSA.
Heijmen et al. [29] treated 28 TAAs in 27 patients with
TEVAR. In five patients (18%), the LSAwas transposed first as a
separate procedure to lengthen the proximal landing zone.
None developed paraplegia or paraparesis. The authors
argued that inadvertent ESG placement across the LSA’s
originmay lead to the development of an occlusive thrombus,
resulting in left-upper-extremity ischaemia, despite unim-
peded blood flow and the absence of a pressure gradient at
completion in angiography [12,30]. Moreover, they argued
that LSA obstruction may lead to cerebrovascular insuffi-
ciency in compromised patients due to flow reversal in the
ipsilateral VA, and because that vessel also contributes to the
anterior spinal artery, it is conceivable that flow reversal may
increase the risk of spinal cord ischaemia. Furthermore,
persistent flow in the LSA could result in a retrograde type-II
endoleak [31].
In 2006, Czerny et al. [32] published a series of 11 patients
with TAA or acute dissection. TEVAR was performed after
autologous sequential transposition of the LCCA into the
brachiocephalic trunk and of the LSA into the already
transposed LCCA, or by total arch rerouting with an extra-
anatomical vascular prosthesis. The authors routinely per-
form LSA transposition in any type of chronic disease of the
distal aortic arch prior to ESG placement, with the primary
intention of preserving posterior cerebral circulation, and
not to maintain antegrade perfusion of the left upper
extremity. Furthermore, as do other investigators [29,31],
they emphasise that retrograde perfusion of the aneurysmal
sac via the LSA may result in type-II endoleak formation.
Cambria et al. performed TEVAR in 28 patients [33], six of
whom (21%) required a preliminary LSA transposition to
provide an adequate proximal neck for ESG fixation. All
patients with LSA covering underwent prophylactic revascu-
larisation. The authors’ argument for this was not primarily a
concern for any neurologic or vascular symptoms, but their
concern for significant endoleaks, as they believe that a
majority of the patients will tolerate the LSA’s sacrifice.
A multicentre registry analysis by Buth et al. [34] assessed
the incidence and risk factors for paraplegia and/or
paraparesis and stroke by both univariate and multivariate
regression models of 606 patients with thoracic aortic
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other factors an independent correlation between spinal
cord ischaemia (SCI) and LSA covering without revascularisa-
tion (odds ratio 3.9, p = 0.27). In addition, a neurologic
complication (paraplegia or stroke) developed in 8.4% of the
patients in whom LSA covering was required, compared with
0% of patients following prophylactic revascularisation
( p = 0.049).
3.2. Conditional prophylactic LSA revascularisation
Other authors propose the concept of prophylactic LSA
revascularisation only under certain conditions. Criado et al.
[1] describe their experience with TEVAR in 47 patients with
TAA or type-B aortic dissections. Proximal ESG attachment
was distally within 2 cm of the LSA in 21 patients and
proximal to the LSA in 10. In five cases, the ESG was placed
across the origin of the LSA without prior revascularisation,
and in eight patients, prophylactic transposition or bypass
surgery was performed to revascularise the LSA to allow ESG
placement more proximally into the mid/distal aortic arch.
The authors did not experience any instance of paraplegia or
stroke. They believe that LSA coverage is generally safe, even
without prior transposition or bypass, but they recommend
ascertaining the angiographic patency of the contralateral VA
beforehand. Secondary revascularisation is easily achievable
should vertebrobasilar or arm ischaemia develop. On the
other hand, preliminary transposition of the LSA is the
preferred strategy to prevent a type-II endoleak [29,31—33].
Schoder et al. [15] treated 58 patients with TEVAR, who
required fixation of the ESG at the origin of arch vessels. In
nine patients with TAA, the LSA originated within the
aneurysm. The remaining patients presented a distance
between the LSA and aneurysm or intimal tear of the
dissection of less than 15 mm. Intentional coverage of the LSA
resulted in complete occlusion in eight and partial occlusion
in 24 patients. Primary surgical revascularisation of the LSA
was performed in patients with a dominant left VA, with a
marked stenosis of the right VA or an occluded internal
carotid artery. In that study, 26 patients underwent surgical
revascularisation of the supra-aortic vessels before TEVAR.
Intentional covering of the LSA without previous revascular-
isation was performed in patients in whom two VAs were of
good and equal calibre. Five of eight patients (63%) with
complete occlusion of the LSA without prophylactic LSA
revascularisation experienced adverse events. Two patients
suffered major peri-procedural complications (one had
paraplegia and the other critical arm ischaemia), and three
had minor complications (two incomplete subclavian steal
syndromes with temporary dizzy spells and one with
temporary arm claudication). Secondary transposition of
LSA was necessary in two patients, one to treat critical arm
ischaemia, and one to treat a type-II endoleak. The authors
argue that a lack of collaterals may lead to acute and sub-
acute ischaemic symptoms following acute LSA occlusion,
compared with the absence of symptoms in patients with
atherosclerotic LSA stenosis or occlusion, where the slow
progression of the stenosis promotes collateral vessel
development [35]. They also emphasise that the combination
of LSA coverage and the presence of a severely stenotic or
hypoplastic right VA can cause vertebrobasilary ischaemiaand, thereby, irreversible neurological complications due to
the incapacity of the contralateral VA to supply blood to the
posterior circulation. In accordance with other studies
[36,37], it is suggested that a non-compromised blood supply
between the anterior and posterior circulation via the
posterior communicating artery (PCOMA) [23] seems essen-
tial to avoid cerebral infarction. The authors therefore
conclude that, before intentional LSA occlusion, one should
evaluate the carotid arteries, VAs as well as the circle of
Willis, to minimise the risk for ischaemic cerebral disorders.
Surgical revascularisation of the LSA is recommended in
patients in whom any concern for an ischaemic event exists.
Transposition of the LSA or LSA-to-LCCA bypass surgery
followed by ligation of the proximal LSA was also recom-
mended to avoid retrograde perfusion of the aneurysm sac in
distal arch aneurysms or to avoid retrograde perfusion of the
false lumen in dissections.
Weigang et al. [38] evaluated the neurological complica-
tion rate in 20 patients with TAA or type-B aortic dissections
undergoing TEVAR with complete (n = 14) or partial (n = 6)
coverage of the LSA. All patients were subjected to a detailed
preoperative exploration of vascular anatomy and pathology
by means of Doppler ultrasound, computed tomography (CT)
or magnetic resonance imaging (MRI) scan. In one patient
with right carotid artery and VA occlusion, a LCCA-to-LSA
bypass was performed prophylactically. After surgery, all
patients underwent neurological examination and Doppler
ultrasound to detect any neurological and peripheral vascular
complications. Two patients developed late adverse neuro-
logical events: one developed a brainstem infarction due to
an acute postoperative occlusion of the right VA causing left-
sided facial paresis, dysarthria, hemiparesis and hemi-
hypoaesthesia. That patient underwent a secondary LSA
transposition to prevent further brainstem infarction due to
impaired perfusion of the vertebrobasilary arteries. Another
patient developed impaired binocular vision in conjunction
with dizziness. Peripheral symptoms related to the LSA
occlusion were observed in five of 14 patients as sensory and
motoric deficits of the left hand and arm. However, the
symptoms were mild and in four of them, they improved over
time, making LSA revascularisation unnecessary. One was
treated surgically with LCCA-to-LSA bypass and proximal LSA
ligation, leading to an improvement of symptoms. Several
groups of patients have been identified as needing prophy-
lactic revascularisation of the LSA. These include coronary
bypass grafting (CABG) patients with a patent left internal
mammary artery (LIMA) because LSA occlusion in such cases
may cause myocardial ischaemia [39]. Further, carotid artery
or VA stenosis, as well as anatomic variants, such as the origin
of the left VA from the aortic arch, the absence of fusion
between the VAs and the basilary artery, an otherwise
functionally compromised circle of Willis or aberrant
subclavian arteries (lusoria) do not permit LSA occlusion
without previous revascularisation, as in the presence of a
covered lusorian artery, it carries the increased risk of
consecutive cerebellar infarction [35,40]. Weigang et al.
recommended that in patients with supra-aortic vessel
pathology, prophylactic transposition of the LSA or LCCA-
to-LSA bypass is required prior to LSA covering.
In 2006, Peterson et al. [18] attempted to develop
guidelines for managing patients scheduled for TEVAR, who
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branches. Their experience consisted of 70 patients, of whom
30 (43%) presented involvement of the proximal aortic
landing segment or in whom it was adjacent to the supra-
aortic branches. In all 30 patients, the LSAwas covered by the
proximal end of the ESG. Coverage of the LSAwasmanaged by
transposition of the LSA into LCCA (20 patients) and by bypass
(two patients). In eight patients, no prophylactic revascu-
larisation was performed. In the latter group, five patients
experienced acute complications, including four patients
who experienced a stroke and one who developed sympto-
matic subclavian steal syndrome requiring secondary LSA
transposition. Of the four stroke patients, two showed
infarction confined to distribution in the posterior circulation
and ipsilateral to the covered LSA. Further imaging
examination revealed the absence of the contralateral VA
in both of those patients. In the two other patients (one of
whom died), stroke was likely due to athero-embolisation
from the aortic arch. By contrast, there were no strokes and
no procedure-related deaths in the group of 22 patients, who
had undergone prophylactic revascularisation. In the remain-
ing 40 patients with thoracic aortic pathology distal to the
supra-aortic branches, there was only one reported stroke.
Furthermore, no late endoleaks related to retrograde
aneurysmal sac perfusion from the LSA were reported. Based
on their experiences, Peterson et al. recommended prophy-
lactic LSA revascularisation before TEVAR in case of proximal
thoracic aortic pathology arising within 15 mm from the LSA,
especially when the dominant VA arises from the ipsilateral
LSA. Moreover, prophylactic revascularisation should also be
considered when multiple intercostal arteries are covered in
patients with extensive descending thoracic aortic pathol-
ogy. In line with Weigang et al. [38], LSA transposition is
indicated in patients, who may undergo future coronary
revascularisation (with a LIMA graft), and an LSA-to-LCCA
bypass rather than LSA transposition (to circumvent unsafe
clamping proximal to the LIMA) should be performed in
patients, who have already undergone CABG with LIMA as
bypass graft. In accordance with Schoder et al. [15],
prophylactic revascularisation should be considered to
prevent type-II endoleak in these patients.
Go¨rich et al. [30] performed TEVAR with full coverage of
the LSA without prior revascularisation in 23 patients. Three
patients (13%) experienced mild neurovascular symptoms
after a mean follow-up of 12.1  7.3 months. These include a
temperature difference between the upper extremities with
no loss of strength, exercise-dependent paraesthesia as well
as non-exercise dependent, intermittent and completely
reversible dizziness. They documented preoperative patency
of both VAs in 18 patients. The remaining five patients
underwent LSA coverage in an emergency setting, without
prior demonstration of contralateral VA patency. The authors
concluded that covering the LSA is well tolerated. However,
similar to Criado and Schoder [1,15], Go¨rich et al. emphasise
that the LSA should only be covered in patients whose right VA
is not pathological and no anatomical variant is present.
Tiesenhausen et al. [22] published a series of 10 patients
suffering from TAA or aortic dissection and scheduled for
TEVAR: two underwent prophylactic LSA transposition.
During the mean follow-up of 18 months, two patients with
aortic dissection as a primary pathology and withoutprophylactic revascularisation developed a type-II endoleak
with retrograde flow via re-entries and a false aortic channel.
Because of the absence of thrombosis, one patient under-
went transposition and the other LCCA-to-LSA bypass. A third
patient developed subclavian steal syndrome with vertigo
and left-arm claudication resolved by a postponed LSA
transposition. Another two patients suffered from occasional
vertigo but refused further surgical intervention. Like other
authors [1,15,29,30,38], we recommend that significant
stenosis or obstruction in the VAs or internal carotid arteries
should be ruled out before TEVAR with intentional LSA
occlusion to guarantee sufficient collateral blood flow.
Tiesenhausen et al. [22] also consider, along with Heijmen
[29] that intentional occlusion of the LSA might influence the
spinal cord’s upper blood supply. Tiesenhausen et al. [22]
conclude that intentional occlusion of the LSA (without
prophylactic revascularisation) in TEVAR seems to be a safe
procedure. Although all patients with intentionally occluded
LSA did not develop postoperative neurological symptoms or
left-arm ischaemia, three of eight patients (37.5%) without
prior revascularisation developed a subclavian steal syn-
drome with vertigo and resting pain or claudication during
follow-up. The indication for a secondary revascularisation
was set in all three patients (of whom only one was
revascularised). Two additional patients, who had a type-II
endoleak after the primary procedure, received revascular-
isation 3 months later. Five of eight patients (62.5%) with
intentional occlusion of the LSA without prophylactic
revascularisation were said to require late revascularisation,
which seems to contradict the authors’ own conclusion.
Rehders et al. [40] reported the clinical history of 22
TEVAR patients, who underwent occlusion of the LSA during
ESG placement. The need for post-interventional transposi-
tion of the LSA was evaluated. They performed either high-
resolution contrast-enhanced CT or three-dimensional (3D)
MR angiography (MRA) before TEVAR to exclude vertebral/
carotid or coronary stenoses and to visualise the LSA in
relation to the aortic pathology. If intentional coverage of the
LSA ostium was unavoidable, a balloon occlusion test of the
LSA was performed to screen for left-arm ischaemia. In their
series of 22 patients in whom the LSA was occluded by the
ESG, no patient was symptomatic during the 30-min LSA
balloon occlusion test. Further, ESG occlusion of the LSA was
followed by a mean 26% differential in systolic blood pressure
between the right and left arms. However, no patient showed
any signs of malperfusion during hospitalisation. During a
mean follow-up of 24  15.8 months, 15 (68.2%) patients
remained completely asymptomatic, revealing no functional
deficit or temperature difference between the arms, while
seven patients reported mild subclavian-steal-syndrome
symptoms. No patient required any secondary surgical
intervention. Rehders et al. challenge the need for
prophylactic transposition or bypass of the LSA. They cite
publications [41,42] that show that most patients with an
ultrasound-documented subclavian steal are asymptomatic,
and argue that collateral perfusion of the left arm seems
adequate as flow inversion from a normal contralateral VA to
the left VA can compensate for intentional LSA coverage.
They point out that surgical treatments correlate with a
mortality of 1.2—5% when performed on occlusive LSA
lesions, thereby increasing the overall risk of TEVAR, and
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should be reserved for those patients who develop ischaemic
symptoms or for those who have a potentially compromised
collateral arm supply, including patients presenting previous
CABG with LIMA, a critically stenosed carotid and/or VAs, or
functional compromise of the circle of Willis or anatomical
variants. They maintain that pre-interventional balloon
testing is unnecessary as long as appropriate functional
and anatomical connections to the basilar artery have been
documented by MRA and normal flow directions in both VAs
are visible in Doppler flow investigations.
Caronno et al. [17] also advocate individual prophylactic
bypass or transposition of the LSA after coverage of the LSA
ostium. They performed a retrospective analysis of 11
patients with TEVAR and intentional coverage of the LSA
ostium. Mean systolic pressure in the left arm decreased by
38  17 mmHg, and no patient showed any signs of left-arm
malperfusion during hospitalisation. Paraplegia was not
observed, but one patient developed a transient ischaemic
attack. During a mean follow-up of 19  8 months, all
patients were completely asymptomatic, presenting no
functional deficits or temperature differentials between
the two arms. Caronno et al. also mention that, besides the
VA, other muscular arterial branches in the neck and shoulder
region serve as collaterals when occlusion of LSA occurs
[30,43,44]. They conclude that intentional occlusion of the
LSA is well tolerated, that surgical LSA revascularisation
procedures add to TEVAR’s invasiveness and overall risk and
that (in accordance with Rehders et al.) these procedures
should be reserved for those patients who develop ischaemic
symptoms or who may have a compromised collateral arm
supply. Again, in accordance with many authors
[1,15,22,29,30,38,40], they emphasise that intentional
occlusion of the LSA ostium may influence the perfusion of
the upper spinal cord segment. They also recommend careful
screening for anomalies of the supra-aortic arteries, as have
many authors [15,29,31—33,38]. Caronno et al. did not
record cases of type-II endoleak from the LSA in their series,
and they suggest that coil embolisation can be easily
performed in such a case through a catheter placed in the
LSA from the left arm.
Reece et al. [45] report a series of 27 patients undergoing
TEVAR with LSA coverage. Seven patients (25.9%) required
prophylactic LSA revascularisation (all had LSA bypass) based
on their specific vascular anatomy and the estimated risk of
ischaemic complications (e.g., presence of LIMA graft).
Three patients developed anterior cerebral neurological
deficits after TEVAR (one patient with prophylactic LSA
revascularisation and two without). Symptoms resolved
during initial hospital stay in two of these patients, includingTable 1. Indications and considerations for LSA revascularisation in TEVAR with LSA
Indications for preoperative LSA revascularisation
Isolated posterior cerebral circulation
Dominant left vertebral artery
Patent LIMA to LAD
Anomalous subclavian or vertebral arteries
Used with kind permission from: Elsevier Inc. Modified from: Ann Thorac Surg
CABG: coronary artery bypass grafting; LAD: left anterior descending artery; and LIthe one with revascularisation. The third experienced
persistent memory difficulties. All three neurological events
were attributed to embolic phenomena rather than hypo-
perfusion due to LSA exclusion. No patient suffered from
paraplegia. The authors concluded that preoperative imaging
predicted well the need for prophylactic LSA revascularisa-
tion, but did not eliminate the occurrence of cerebrovascular
accidents (CVAs), which were most likely embolic in nature.
Four other patients (20%) developed symptoms of subclavian
steal syndrome or late left-arm claudication (between 3 and
26 months after TEVAR) and underwent LSA revascularisation
with LSA-to-LCCA bypass. These authors prefer selective
revascularisation of the LSA using preoperative imaging in
case of vertebrobasilar isolation: aberrant vascular and
patent internal mammary conduits to the coronaries (Table
1). They argue that their data suggest that the need for LSA
revascularisation may be greater than that reported by most
other groups performing these procedures.
In a single-centre, retrospective investigation by Woo
et al. [46], the LSA was covered in 70 of 308 patients with
TEVAR. Forty-two patients underwent elective revascular-
isation of the LSA, consisting of both LSA transposition (n = 5)
and LSA bypass (with ligation n = 3 and with coil embolisation
n = 34). Mean follow-up was 11 months. No paraplegia
developed, the stroke rate was 8.6% and no strokes were
related to LSA coverage because there were no posterior
strokes. Stroke rates were similar in both groups with or
without revascularisation (7% vs 11%). No left-arm symptoms
developed in the LSA-revascularised patients, whereas the
five (18%) patients without LSA revascularisation developed
symptoms in the left arm. Two required LSA revascularisa-
tion, and no permanent left-upper-extremity dysfunction or
ischaemia developed in any patient. They conclude that
prophylactic LSA revascularisation is not absolutely neces-
sary except in patients with a patent LIMA bypass; however,
they also mention in the article that they now perform LCCA-
to-LSA bypass on all elective zone 2 TEVAR cases. Melissano
et al. [44] performed TEVAR in 30 patients, 18 of whom
underwent LSA ostium coverage. Prophylactic revascularisa-
tion of the LSA was done in the first three patients only.
Paraplegia or neurologic sequelae were not observed in this
group. Five cases of type-II endoleak were observed that
resolved after prevertebral ligature of the vessel during the
same procedure. This group also suggests that prophylactic
revascularisation of the LSA is only necessary (1) when the
contralateral VA and the branches from which it originates
are not patent, (2) in the presence of a previous myocardial
revascularisation with the LIMA, (3) a lusoria artery or (4) an
AV shunt for haemodialysis in the left arm and (5) finally in
left-handed patients. Prophylactic revascularisation of thecoverage.
Considerations for preoperative LSA revascularisation
Risk for type-II endoleak from covered LSA
Potential need for LIMA for future CABG
Potential extensive intercostals coverage (paraplegia risk)
Younger patients
Left-handed professionals
84:1201—5.
MA: left internal mammary artery.
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covering of large parts of the thoracic aorta in combination
with previous abdominal aortic surgery, to prevent para-
plegia. These authors conclude that prophylactic surgical
revascularisation is required for cases involving the left
common carotid and innominate arteries, not for coverage of
the LSA.
In an extension of their first study [47], Melissano et al.
report coverage of the LSA ostium in 27 patients, 11 of whom
underwent prophylactic revascularisation. They observed
two cases of delayed (range 1—3 days) transitory paraparesis
(which resolved by cerebral spinal fluid (CSF) drainage) in
patients with extensive descending thoracic aorta involve-
ment and LSA coverage without prior revascularisation.
3.3. No prophylactic LSA revascularisation
Riesenmann et al. [48] do not support prophylactic
revascularisation. They described TEVAR in 24 patients with
partial (10 patients, 42%) or complete (14 patients) coverage
of the LSA. None underwent prior revascularisation. Mild left-
upper-limb symptoms developed that did not warrant
intervention in three (15.8%) patients, and rest pain
developed in one (5.3%), which was treated by insertion of
an LSA stent. Three CVAs (10.7%) were observed. Two
occurred in patients in whom the LSA had been completely
covered: one was due to embolism and the other to
hypotension that occurred during an intra-operative cardiac
arrest, leading to a CVA in a left frontoparietal watershed
distribution. The third CVA was assessed as an embolic event
in a patient with partial covering of the LSA. In this study, four
of 19 patients (21%) with complete cessation of antegrade
flow through the LSA experienced left-upper-extremity
symptoms, but only one (5%) required an intervention. They
confirmed that the 21% incidence of left-upper-extremity
symptoms is consistent with previous observations after LSA
coverage without revascularisation [22,30,40,44]. However,
they also recommend pre-procedural imaging to evaluate the
contralateral VA, carotid arteries and the presence of an
intact circle of Willis.
A meta-analysis and systematic review by Cooper et al.
[49] reveals a higher risk of both CVA and SCI with coverage of
the LSA during TEVAR. However, regarding the higher risk of
CVA after LSA coverage, they found that relatively few of the
published studies reached statistical significance alone owing
to insufficient numbers. In addition, they posit that CVA after
TEVAR has multiple causes, thus making prophylactic
revascularisation not definitively protective. However, the
risk for SCI did not differ significantly between patients with
no LSA coverage and those with LSA coverage and
revascularisation, suggesting a protective role for prophy-
lactic revascularisation in preventing SCI (although relevant
study numbers were very low in that regard). They concluded
that prophylactic revascularisation does not seem to prevent
the occurrence of CVAs, but that it may reduce the risk of SCI.
In an article published 2 years earlier by the Tiesen-
hausen’s team, Hausegger [50] presented three case
reports of patients with aortic type-B dissection and one
patient with a thoracic aneurysm, who underwent TEVAR
during which the LSA ostium was covered. All their patients
underwent TEVAR without prior surgical LSA revascularisa-tion. None had any symptoms suggestive of a subclavian
steal syndrome or left-arm ischaemia. However, left-arm
radial pulses and blood pressure remained significantly
reduced. The follow-up period ranged from 14 to 20
months. On follow-up duplex scanning, all four patients
presented inverse flow in the left VA. Secondary transposi-
tion of the LSA to the LCCA had therefore not been
required. The authors state that they rely on natural
collateralisation via the left VA to sustain perfusion of the
left arm after covering the LSA, supporting that position by
the fact that their initial experience with LSA occlusion did
not cause problems in patients undergoing TEVAR, and that
the only measurable effect was a significant drop in
arterial blood pressure and reversed flow in the left VA. In
addition, owing to collateral flow via the VA, most patients
with subclavian steal syndrome are asymptomatic, as are
children with aortic coarctation in whom the LSA is
transected and used as an aortic interposition graft
without bypass to the distal subclavian artery stump.
Furthermore, the perfusion of the spinal cord, which
derives some of its blood supply from the VA, should be
maintained regardless of the direction of the flow in the
VA. They also emphasise the additional invasiveness and
overall risk of treating TAA or dissection patients, most of
whom have significant co-morbidities. Such risk is mirrored
by mortality rates of 1.2—5% reported for LSA-to-LCCA
bypass or LSA transposition, when performed on occlusive
lesions of the LSA.
In a separate article by Go¨rich’s working group, Pamler
et al. [51] reported intentional covering of the LSA in nine of
14 patients with isolated type-B aortic dissection who
underwent TEVAR. The authors did not perform any
prophylactic revascularisation of the LSA before coverage.
An incomplete paraparesis developed in one patient due to
acute anterior spinal artery syndrome at level T10/11. The
neurological symptoms decreased within 24 h without any
further management (i.e., no CSF drainage). Spiral CT
revealed complete thrombosis of the false lumen from the
LSA to superior mesenteric artery. Furthermore, they
observed eight pairs of intercostal arteries originating from
the false lumen, thereby explaining the anterior spinal artery
syndrome. The authors observed no clinical signs of
malperfusion of the left arm or reperfusion of the false
lumen (endoleak) via the LSA in any of these nine patients,
who had undergone coverage of the LSA and no prophylactic
revascularisation procedures.
In their subsequent report [52], Sunder-Plassmann et al.
describe the experience with TEVAR in 45 patients with
aneurysms of the descending thoracic aorta in elective and
emergency cases. The LSA had to be covered without prior
revascularisation in 12 patients. The LSA was transposed
later in one patient, who had requested the surgery. The
authors carried out a pre-procedural duplex evaluation of
the ipsi- and contralateral carotid circulation to rule out
occlusions and stenoses, observing no cases of left-hand
ischaemia, subclavian steal syndrome or clinically
relevant spinal cord ischaemia. One transient neurological
deficit occurred in a patient, who died 7 days later
from undetected iatrogenic aortic dissection. Another
patient died after 4 months from brain infarction
(Table 2).
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Table 2. Relevant studies concerning endograft coverage of the LSA and prophylactic LSA revascularisation: Diagnoses, surgical therapy, complications (all in number of patients) and cumulative risk (in %) for neurological
complications as related to treatment option.
Authors [Ref.] (PR) Diagnosis total
patient group
Patients (n)
with isolated
coverage of LSA
Primary
T or BP
Sec. T or BP
or LSA stent
Complications a Type-II endoleak Cumulative risk
for neurological
complicationsNo T or BP Stroke Paraplegia Arm malperfusion
Grabenwo¨ger [26] TAA 19, diss. 2, other 0 9 9 T 0 0 0 0 0 0%
0
Grabenwo¨ger [28] TAA 2, diss. 11, traum 2, other 4 19 0 0 0 0 0 0 0%
19 1 0 1 1 1 5.2%
Heijmen [29] TAA 5 8 T 0 0 0 0 4 of 28 (whole group) 0%
0
Czerny [32] TAA 8, diss. 3 9 9 T 0 0 0 0 0 0%
0
Cambria [33] TAA 18, diss. 4 (chronic), other 6 6 6 T 0 0 0 0 3 0%
0
Buth [34] TAA 291, other 315 (inc. 67 traum) 159 40 T/BP 0 0 0 0 0 0%
119 0 5 6 0 0 9.2%
Authors [Ref.] (cond. PR)
Criado [1] TAA 31, diss. 16 5 0 0 0 0 0 0 0%
5 0%
Schoder [15] TAA 32, diss. 19, traum. 4, other 3 8 0 0 0 0 0 0 0%
8 2 2 1 2 2 37.5%
Weigang [38] TAA 10, diss. 10 (chronic 4) 11 1 T 0 0 0 0 0 0%
10 1 T 2 0 0 0 20%
Peterson [18] TAA 15, diss. 9 (chronic 5), traum 6 30 20 T, 2 BP 0 0 1 0 0 4.5%
8 1 T 5 0 1 0 62.5%
Go¨rich [30] TAA 3, diss. 9, other 11 23 0 0 0 0 0 0 0%
23 0 0 0 2 0 0%
Tiesenhausen [22] TAA 3, diss. 7 10 2 T 0 0 0 0 0 0%
8 2 T, 1 BP 0 0 1 2 0%
Rehders [40] TAA 39, diss. 128 (all elective cases), other 4 22 0 0 0 0 0 0 0%
22 0 1 0 7 0 4.5%
Caronno [17] TAA 3, diss. 5, other 3 11 0 0 0 0 0 0 0%
11 0 1 0 0 0 9%
Reece [45] TAA 15, diss. 3 (chronic), other 9 (acute traum 7) 27 1 T, 6 BP 0 0 0 0 0 0%
20 4 BP 3 0 3 0 15%
Woo [46] TAA 47, diss. 16 (chronic 1), other 7 (traum 2) 70 5 T, 37 BP 0 3 0 0 0 7%
28 2 BP 3 0 5 (18%) 0 11%
Melissano [44] TAA 11, diss. 2, other 5 18 3 BP 0 0 0 0 5 0%
15 0 0 0 0 0 0%
Melissano [47] TAA 53, diss.3, other 8 (traum 2) 27 2 T, 9 BP 0 0 0 0 0 0%
16 0 0 2 0 0 12.5%
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b4. Summary
ESG placement in the proximal part of the descending
aorta often requires covering the LSA ostium to extend the
proximal landing zone with a minimum of 2 cm of normal
aortic wall. Covering the LSA can lead to vascular and
neurological complications and to type-II endoleak by
retrograde perfusion from the LSA into the aneurysm sac
or the dissection’s false lumen in certain patients. Several
authors [6,29,32,33,38], therefore, recommend prophylactic
revascularisation of the LSA before coverage in high-risk
patients. Others [48,50,51] criticise every additional surgical
procedure by suggesting that they add to the invasiveness
and overall treatment of TAA or dissection patients [50]. In
addition, they draw attention to the 1—5% mortality rates
described in association with LSA-to-LCCA bypass or LSA
transposition [50], although these data refer to occlusive
atherosclerotic lesions of the LSA and not to LSA coverage by
ESGs. Another argument in favour of a procedure without
prophylactic LSA revascularisation is that LSA coverage is a
well-tolerated procedure in patients with normal (no
apparent angiographic lesions) supra-aortic branches
[30,50]. When collateral blood flow from the muscular
arterial branches in the neck and shoulder girdle [17] and via
the contralateral VA [50] is adequate, most patients with
subclavian steal syndrome are asymptomatic [50]. This may
be difficult to maintain for incipient aortic conditions, for
instance, in acute aortic dissection or some traumatic
transections. After systematically probing the literature to
analyse whether the hypothesis that the putative absence of
a collateral network in acute aortic conditions leads to a
higher frequency of neurological events with coverage of the
LSA ostium is true, we found that unequivocal information on
this paradigm is lacking. This is due to low patient numbers
and few specifics by the authors in differentiating emer-
gency, acute, chronic and elective cases and in reporting
(neurologic) complications.
Over the past years, most authors have concluded that
prophylactic LSA transposition or LSA-to-LCCA bypass surgery
is advantageous. This approach demands careful preopera-
tive evaluation by Doppler ultrasound, computed tomogra-
phy angiography (CTA) or MRA of supra-aortic vascular
anatomy and pathology (significant stenoses and occlusions)
before deciding whether prophylactic LSA transposition or
LSA-to-LCCA bypass is necessary. For instance, a study by
Manninen et al. [23] addressed the risk for posterior cerebral
infarction that can evolve in the presence of vertebrobasilar
insufficiency following LSA coverage. They performed a post-
mortem anatomic study on 62 forensic autopsy cases in which
the existence and diameter of the right VA and PCOMA were
assessed with craniocervical CT and MRA. In 5.4% of cases,
they were able to identify a substantial risk for acute
neurological complications after unprotected closure of the
LSA due to the hypoplasia of the right VA above the posterior
inferior cerebellar artery in conjunction with an incomplete
PCOMA, and in 3.3% the risk for neurologic complications was
considered possible because of isolated right VA hypoplasia.
They concluded that when the LSA is closed, insufficient
posterior cerebral circulation due to individual anatomy
occurs relatively infrequently, but to avoid complications,
careful imaging of the right VA up to the basilar artery is
E. Weigang et al. / European Journal of Cardio-thoracic Surgery 40 (2011) 858—868866mandatory, and if proven hypoplastic, PCOMAs’ imaging is
necessary.
Another point has been raised by Botta et al. while
studying endovascular treatment for acute traumatic trans-
ection of the descending aorta in 31 patients [53]. They
remark that flow compensation throughout the circle ofWillis
is a dynamic process, which can be influenced by the
diameter of the posterior communicating arteries and
vasomotor regulation which, in turn, may be influenced by
cerebral oedema or general anaesthesia. In any case, we
believe that these traumatic patients should undergo
treatment as soon as the surgeon perceives that there is
no other limiting concomitant injury more ominous than the
aortic disease.
However, recent data [34,45,49] reveal that a high
percentage of patients undergoing TEVAR with LSA coverage
need conditional prophylactic LSA transposition or LSA-to-
LCCA bypass surgery due to abnormal supra-aortic vascular
anatomy or existing supra-aortic pathology. Moreover, the
same studies report a significant incidence of devastating
neurologic complications in the remaining non-revascu-
larised group.
The reported incidence of stroke varies from 2% to 15%
[15,18,34,38,45,46,48], whereby the causes seem multi-
factorial. Although a significant number of strokes occur in
the posterior circulation and can be attributed to localised
anatomical vascular malformations or vascular pathology
directly linked to LSA coverage, still another significant
number does occur in other parts of the brain and has other
aetiology, for instance, hypoperfusion or emboli. It is
generally known that LSA covering without prophylactic
revascularisation leads to a significant higher incidence of
stroke compared with LSA covering with prophylactic
revascularisation. Nevertheless, a substantial part of all
presenting strokes do occur in patients with TEVAR without
LSA coverage, and even in some with LSA covering with
prophylactic revascularisation. TEVAR patients, therefore,
still present an elevated risk of perioperative stroke (due to
guidewire manipulations and ESG deployment during the
procedure).
SCI is another serious potential complication of TEVAR
with an incidence of between 0% and 5%, although few data
are available. Proposed pathophysiologic mechanisms
include, for instance, LSA coverage leading to reduced blood
flow to the VA and thus to the spinal cord via the spinal artery
and/or to reduced anterior spinal and costocervical blood
flow by coverage of intercostal vessels by one or more stent
grafts. Further suggested risk factors for compromised spinal
cord perfusion in TEVAR are the occlusion of intercostal
arteries by the stent grafts at the T8-12 level, previous
abdominal aortic surgery, occlusion of internal iliac arteries
and renal failure. Overall, the risk of SCI after TEVAR is
significant and is not to be underestimated because of the
condition’s severity.
Unfortunately, many of these neurological conditions do
not resolve after secondary revascularisation. It thus may be
necessary to perform prophylactic LSA transposition or LSA-
to-LCCA bypass surgery in elective patients scheduled for
TEVAR with LSA coverage, also because their additional
surgical risk is low as they are usually free of occlusive
atherosclerotic lesions of the LSA.Subclavian steal syndrome is common after TEVARwith LSA
coverage,withan incidenceof5—37.5%.Most of thesepatients
areasymptomaticdueto theflowinversion fromtheVAand the
presence of collaterals in the neck and shoulder girdle, as
symptoms, if they occur, tend to be mild and transient.
The incidence of left-arm ischaemia is reported between
0% and 36%. Symptoms are mostly transient and consist of a
cooler hand, exercise-induced paraesthesias of the left arm
and hand, claudication and rest pain or even distal digital
trophic changes. Prophylactic revascularisation prevents
such symptoms.
Overall, left-upper-extremity symptoms occur in about
20% of patients, who undergo TEVAR and LSA coverage
without prior revascularisation. When one considers the high
frequency of this complication together with the substantial
threat of severe neurologic sequela (i.e., stroke or SCI after
TEVAR with LSA coverage and without prophylactic revascu-
larisation), a prophylactic revascularisation is strongly
recommended.
By contrast, covering of the LSA without prophylactic
revascularisation of the LSA is justified in acute unstable
patients (e.g., patients with aortic rupture) because of the
shortage of time to perform prophylactic LSA transposition or
LSA-to-LCCA bypass surgery. As we anticipate the absence of a
patent collateral network in those conditions, secondary
revascularisation of the LSA is indicated after the emergency
situation.
The LSA-to-LCCA bypass or LSA transposition procedure
may itself be hazardous and there are few reports that
document cases that do not proceed to TEVAR because of
complications related to the preparatory LSA revascularisa-
tion. Future studies are necessary to distinguish whether the
morbidity of TEVAR without prophylactic revascularisation is
significantly greater than the combined morbidity of TEVAR
with prophylactic revascularisation. Until databases and
reports include all patients on an intention-to-treat basis,
definitive evidence that one approach is superior to another
is difficult to acquire. Nevertheless, such pathology-based
rather than procedure-based databases would incorporate
the added complication rate of the prophylactic surgical
procedure in the total equation.
Finally, prophylactic LSA transposition or LSA-to-LCCA
bypass surgery and TEVAR is recommended for elderly and
high-risk patients not suitable for conventional open surgery.
This is based on the fact that, so far, long-term results
regarding integrity and durability of the stent-graft device
are missing [53]. However, in traumatic aortic rupture,
descending aneurysm rupture and in acute aortic dissection
type-B patients with complications, where conventional
surgery exhibits high mortality and morbidity rates, TEVAR is
recommended as first-line therapy.5. Conclusion
Prophylactic revascularisation of the LSA before coverage
through a stent graft is necessary when careful preoperative
imaging reveals abnormal supra-aortic vascular anatomy or
supra-aortic pathology. To avoid potentially devastating
neurological complications in the absence of revascularisa-
tion, elective patients undergoing LSA coverage during TEVAR
E. Weigang et al. / European Journal of Cardio-thoracic Surgery 40 (2011) 858—868 867should be subjected to prophylactic LSA transposition or LSA-
to-LCCA bypass surgery before TEVAR. It would appear that
only in acute unstable patients immediate covering of the
LSA without prophylactic revascularisation of the LSA is
justified. In these cases, LSA revascularisation should be done
after the emergency situation.
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